NMNAT2 antibody
Principal name
NMNAT2 antibody
Alternative names for NMNAT2 antibody
NMN adenylyltransferase 2, Nicotinamide mononucleotide adenylyltransferase 2
Ncbi ID
9606, NP_055854, NM_015039, NP_733820, NP_055854.1, NP_780669.1, NM_001048042, NM_170706
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB)
Background of NMNAT2 antibody
- Kit Component:
- - KN311075G1, Nmnat2 gRNA vector 1 in pCas-Guide vector
- KN311075G2, Nmnat2 gRNA vector 2 in pCas-Guide vector
- KN311075D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Berger F., et al (2005). J. Biol. Chem. 280:36334-36341 Sorci L., et al (2007). Biochemistry 46:4912-4922
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP300889 | NMNAT2 (transcript variant 2) |
||||
| Recombinant protein of human nicotinamide nucleotide adenylyltransferase 2 (NMNAT2), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY414841 | NMNAT2 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR214703L2V | Lenti ORF particles, Nmnat2 (GFP-tagged ORF) - Rat nicotinamide nucleotide adenylyltransferase 2 (Nmnat2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR214703L1V | Lenti ORF particles, Nmnat2 (Myc-DDK-tagged ORF) - Rat nicotinamide nucleotide adenylyltransferase 2 (Nmnat2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||




